News

LGM Pharma announced that it has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. The combination brings together LGM Pharma’s global leadership in Active Pharmaceutical Ingredient (API) sourcing, distribution and supply chain management...

Samsung Biologics (207940.KS) announced a plan to expand its Drug Product (DP) capability in line with increasing market demand and to ensure flexible production capabilities for new and existing clients. Samsung Biologics has been providing aseptic filling and lyophilization services...

LabCorp’s drug development business, Covance, has acquired GlobalCare, a provider of patient-centric decentralized clinical trials support services. This acquisition will expand Covance’s decentralized clinical trials capabilities globally, enabling recruitment and increasing access to trials. Covance will leverage GlobalCare’s mobile healthcare...

Avid Bioservices, Inc., a biologics CDMO, and Argonaut Manufacturing Services, a cGMP contract manufacturing organization (CMO) have entered a co-marketing agreement to provide an integrated manufacturing solution including process development, drug substance manufacturing, and drug product manufacturing. The companies...

Abzena, a leading global partnership research organization providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs), has announced a $10M investment of growth capital from Biospring Partners, a New York based investment firm. The new capital...

CPhI Japan organised by Informa Markets announces that, following a detailed review with partners and key industry stakeholders and to ensure the health and safety of our community, the event will be postponed until *April 14-16, 2021. The event organiser’s...

Optimus Pharma said it has received the Drugs Controller General of India (DCGI) approval to manufacture and market Favipiravir 200 mg tablets for the treatment of patients with mild to moderate COVID-19. The drug regulator also approved the company’s subsidiary...